Poetic justice for Watson?

There's an interesting "P.S." to the story of James Watson's early retirement after public outcry when he told a UK newspaper that he believed people of African ancestry were less intelligent - he has 16 times more genes of African origin than the average Caucasian. The company deCODE Genetics performed the analysis using Watson's entire genome, which he linkurl:released publicly;http://www.the-scientist.com/article/display/53415/ this year. "This level is what you wou

Written byAlison McCook
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
There's an interesting "P.S." to the story of James Watson's early retirement after public outcry when he told a UK newspaper that he believed people of African ancestry were less intelligent - he has 16 times more genes of African origin than the average Caucasian. The company deCODE Genetics performed the analysis using Watson's entire genome, which he linkurl:released publicly;http://www.the-scientist.com/article/display/53415/ this year. "This level is what you would expect in someone who had a great-grandparent who was African," linkurl:Kari Stefansson;http://news.independent.co.uk/sci_tech/article3239366.ece of deCODE Genetics told The Independent. "It was very surprising to get this result for Jim." Stefansson linkurl:visited;http://science-community.sciam.com/thread.jspa?threadID=300005381 the offices of Scientific American weeks ago to discuss the project. In October, Watson linkurl:stepped down;http://www.the-scientist.com/blog/display/53766/ as chancellor of Cold Spring Harbor Laboratory in New York after his remarks, which sparked strong public criticism. Neither Stefansson nor a representative of deCODE Genetics responded to requests for comment and a copy of the analysis about Watson's genome.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies